Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma (vol 7, pg 199, 2012)

被引：0
|
作者：
La Madrid, Andres Morales [1 ]
Campbell, Nicholas [2 ]
Smith, Sonali [2 ]
Cohn, Susan L. [1 ]
Salgia, Ravi [2 ]
机构：
[1] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
TARGETED ONCOLOGY | 2013年 / 8卷 / 04期
关键词：
D O I：
10.1007/s11523-013-0291-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / 301
页数：1
相关论文
共 50 条
  • [1] Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
    Andres Morales La Madrid
    Nicholas Campbell
    Sonali Smith
    Susan L. Cohn
    Ravi Salgia
    [J]. Targeted Oncology, 2012, 7 : 199 - 210
  • [2] Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin's lymphoma, and neuroblastoma
    La Madrid, Andres Morales
    Campbell, Nicholas
    Smith, Sonali
    Cohn, Susan L.
    Salgia, Ravi
    [J]. TARGETED ONCOLOGY, 2012, 7 (03) : 199 - 210
  • [3] Erratum to: Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma
    Andres Morales La Madrid
    Nicholas Campbell
    Sonali Smith
    Susan L. Cohn
    Ravi Salgia
    [J]. Targeted Oncology, 2013, 8 : 301 - 301
  • [4] Survival after subsequent non-Hodgkin's lymphoma and non-small cell lung cancer in patients with malignant thymoma
    Parzen, Jacob S.
    Bates, James E.
    Milano, Michael T.
    Dhakal, Sughosh
    [J]. JOURNAL OF THORACIC DISEASE, 2016, 8 (12) : 3605 - +
  • [5] Coexistence of non-Hodgkin's lymphoma and non-small-cell lung carcinoma: Diagnosis and treatment
    Rothenburger, M
    Semik, M
    Hoffmeier, A
    Baba, H
    Kamanbrou, D
    Roos, N
    Schmidt, C
    Scheld, HH
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2002, 50 (01): : 59 - 61
  • [6] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Brandon Golding
    Anita Luu
    Robert Jones
    Alicia M. Viloria-Petit
    [J]. Molecular Cancer, 17
  • [7] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Golding, Brandon
    Luu, Anita
    Jones, Robert
    Viloria-Petit, Alicia M.
    [J]. MOLECULAR CANCER, 2018, 17
  • [8] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib (vol 6, pg 407, 2012)
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2013, 7 : 85 - 85
  • [9] Increasing chemotherapy dose density and intensity: Phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma
    Blayney, DW
    McGuire, BW
    Cruickshank, SE
    Johnson, DH
    [J]. ONCOLOGIST, 2005, 10 (02): : 138 - 149
  • [10] Treatment of ALK-Positive Non-Small Cell Lung Cancer
    Bang, Yung-Jue
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2012, 136 (10) : 1201 - 1204
12345